-
[1]
Marzanna Łusiak-Szelachowska, Beata Weber-Dąbrowska, Andrzej Górski, 2020: Bacteriophages and Lysins in Biofilm Control, Virologica Sinica, 35, 125-133. doi: 10.1007/s12250-019-00192-3
-
[2]
Yinyin Lu, Hongyan Shi, Zhe Zhang, Fang Han, Jinghua Li, Yanbo Sun, 2015: Isolation and characterization of a lytic bacteriophage φKp-lyy15 of Klebsiella pneumoniae, Virologica Sinica, 30, 66-68. doi: 10.1007/s12250-014-3523-x
-
[3]
Youqiang Xu, Yong Liu, Yang Liu, Jiangsen Pei, Su Yao, Chi Cheng, 2015: Bacteriophage therapy against Enterobacteriaceae, Virologica Sinica, 30, 11-18. doi: 10.1007/s12250-014-3543-6
-
[4]
Pengjun Han, Mingfang Pu, Yahao Li, Huahao Fan, Yigang Tong, 2023: Characterization of bacteriophage BUCT631 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in Galleria mellonella larvae, Virologica Sinica, 38, 801-812. doi: 10.1016/j.virs.2023.07.002
-
[5]
Mzia Kutateladze, 2015: Experience of the Eliava Institute in bacteriophage therapy, Virologica Sinica, 30, 80-81. doi: 10.1007/s12250-014-3557-0
-
[6]
Min Li, Donglin Shi, Yanxiu Li, Yuyi Xiao, Mianmian Chen, Liang Chen, Hong Du, Wei Zhang, 2020: Recombination of T4-like Phages and Its Activity against Pathogenic Escherichia coli in Planktonic and Biofilm Forms, Virologica Sinica, 35, 651-661. doi: 10.1007/s12250-020-00233-2
-
[7]
Zhi-ying OU, Rong ZHOU, Yun-shao HE, 2008: YVDD Mutation of Hepatitis B Virus, a Dominant Lamivudine-Resistant Type in Guangzhou, South China, Virologica Sinica, 23, 218-225. doi: 10.1007/s12250-008-2963-6
-
[8]
刘子夜, 齐义鹏, 王业富, 1998: The virus vectors for gene therapy, Virologica Sinica, 13, 101-.
-
[9]
黄现青, 别小妹, 陆兆新, 吕凤霞, 杨淑晶, 2006: In vitro Assays of an Antimicrobial Lipopeptide Produced by Bacillus subtilis fmbJ Against Pseudorabies Virus and Porcine Parvovirus, Virologica Sinica, 21, 426-429.
-
[10]
李伟灿, 孟小林*, 徐进平, 王 健, 鲁 伟, 徐智圣, 2006: High-level Expression of Silkworm Antimicrobial Peptide and Its Anti-infection to BmNPV, Virologica Sinica, 21, 589-593.
-
[11]
Hubert E. Blum, 2008: Molecular Therapy and Prevention of Liver Diseases, Virologica Sinica, 23, 81-92. doi: 10.1007/s12250-008-2953-8
-
[12]
Chunchen Wu, Baolin Li, Xiaoyong Zhang, Kaitao Zhao, Yingshan Chen, Yifei Yuan, Yan Liu, Rongjuan Chen, Dongping Xu, Xinwen Chen, Mengji Lu, 2019: Complementation of Wild-Type and Drug-Resistant Hepatitis B Virus Genomes to Maintain Viral Replication and Rescue Virion Production under Nucleos(t)ide Analogs, Virologica Sinica, 34, 377-385. doi: 10.1007/s12250-019-00143-y
-
[13]
卢曾军, 曹轶梅, 刘在新*, 谢庆阁, 2006: Advance of Adenoviral Vector in Gene Therapy and Vaccine Research, Virologica Sinica, 21, 622-626.
-
[14]
罗端德, 王心禾, 蔡淑清, 刘世威, 韦克奇, 夏金生, 常泉海, 郑继英, 范木生, 1988: Studies on Antiviral Therapy of Epidemic Hemorrhagic Fever, Virologica Sinica, 3, 290-.
-
[15]
Haiwei Wang, Shanshan Song, Jianxiong Zeng, Guohui Zhou, Decheng Yang, Te Liang, Li Yu, 2014: Single amino acid substitution of VP1 N17D or VP2 H145Y confers acid-resistant phenotype of type Asia1 foot-and-mouth disease virus, Virologica Sinica, 29, 103-111. doi: 10.1007/s12250-014-3426-x
-
[16]
张 颖*, 白雪帆, 黄长形, 白宪光, 2004: HIV-1 Coreceptors and Coreceptor-related AIDS Therapy, Virologica Sinica, 19, 182-186.
-
[17]
Victor Krylov, Olga Shaburova, Elena Pleteneva, Sergey Krylov, Alla Kaplan, Maria Burkaltseva, Olga Polygach, Elena Chesnokova, 2015: Selection of phages and conditions for the safe phage therapy against Pseudomonas aeruginosa infections, Virologica Sinica, 30, 33-44. doi: 10.1007/s12250-014-3546-3
-
[18]
Yue Yin, Herman W. Favoreel, 2021: Herpesviruses and the Type Ⅲ Interferon System, Virologica Sinica, 36, 577-587. doi: 10.1007/s12250-020-00330-2
-
[19]
Stephen T Abedon, 2015: Bacteriophage secondary infection, Virologica Sinica, 30, 3-10. doi: 10.1007/s12250-014-3547-2
-
[20]
张明杰, 汪美先, 姜绍谆, 马文煜, 于碧云, 1990: Experimental Studies on the Therapy of Japanese Encephalitis Virus Infected Rhesus Monkeys by Monoclonal Antibodies, Virologica Sinica, 5, 56-.